Current Report Filing (8-k)
October 12 2016 - 1:49PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of the Securities Exchange Act
of 1934
Date of Report (Date of earliest event reported)
October
6, 2016
LEXARIA BIOSCIENCE CORP.
(Exact name of registrant as specified in its charter)
Nevada
|
000-52138
|
20-2000871
|
(State or other jurisdiction of
|
(Commission File Number)
|
(IRS Employer
|
incorporation)
|
|
Identification No.)
|
#950 1130 West Pender Street, Vancouver, BC
|
Canada
|
V6E 4A4
|
(Address of principal executive offices)
|
|
(Zip Code)
|
Registrants telephone number, including area code
(604)
602-1675
LEXARIA CORP.
(Former name or former address, if
changed since last report.)
Check the appropriate box below if the Form 8-K filing is
intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions:
[ ] Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[ ] Soliciting material
pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a
-12)
[ ] Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d
-2(b))
[ ] Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e
-4(c))
Item 4.01
|
Changes in Registrants Certifying
Accountant
|
(a)
|
Previous independent registered public accounting
firm
|
|
|
|
|
(i)
|
On October 6, 2016, Lexaria Bioscience Corp. (the
Company) formally informed MNP LLP of their dismissal as the Companys
independent registered public accounting firm.
|
|
|
|
|
(ii)
|
The reports of MNP LLP on the Companys financial
statements as of and for the fiscal years ended August 31, 2015 and 2014
contained no adverse opinion or disclaimer of opinion and were not
qualified or modified as to uncertainty, audit scope or accounting
principle except to indicate that there was substantial doubt about the
Companys ability to continue as a going concern.
|
|
|
|
|
(iii)
|
The Companys board of directors and audit committee
participated in and approved the decision to change independent registered
public accounting firms.
|
- 2 -
|
(iv)
|
During the fiscal years ended August 31, 2015 and 2014
and through October 6, 2016, there have been no disagreements with MNP LLP
on any matter of accounting principles or practices, financial statement
disclosure or auditing scope or procedure, which disagreements if not
resolved to the satisfaction of MNP LLP would have caused them to make
reference thereto in connection with their report on the financial
statements for such years.
|
|
|
|
|
|
(v)
|
The Company has requested that MNP LLP furnish it with a
letter addressed to the SEC stating whether or not it agrees with the
above statements. A copy of the letter provided by MNP LLP is filed as
Exhibit 16.1 to this Form 8-K.
|
|
|
|
|
(b)
|
New independent registered public accounting
firm
|
|
|
|
|
|
(1)
|
On October 6, 2016, the Company engaged Davidson &
Company LLP, Chartered Professional Accountants as its new independent
registered public accounting firm. During the two most recent fiscal years
and through October 6, 2016, the Company had not consulted with Davidson
& Company LLP, Chartered Professional Accountants regarding any of the
following:
|
|
|
|
|
|
|
(i)
|
The application of accounting principles to a specific
transaction, either completed or proposed;
|
|
|
|
|
|
|
(ii)
|
The type of audit opinion that might be rendered on the
Companys financial statements, and none of the following was provided to
the Company: (a) a written report, or (b) oral advice that Davidson &
Company LLP, Chartered Professional Accountants concluded was an important
factor considered by the Company in reaching a decision as to accounting,
auditing or financial reporting issue; or
|
|
|
|
|
|
|
(iii)
|
Any matter that was subject to a disagreement, as that
term is defined in Item 304(a)(1)(iv) of Regulation
S-K.
|
Item 7.01
|
Regulation FD Disclosure
|
A copy of the news release dated October 6, 2016 announcing the
appointment of a new auditor is filed as Exhibit 99.1 to this current report and
is hereby incorporated by reference.
- 3 -
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of
1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
LEXARIA BIOSCIENCE CORP.
/s/ Chris
Bunka
|
|
Chris Bunka
|
|
CEO, Principal Executive Officer
|
|
Date: October 11, 2016